While vaccines are widely regarded as one of the most cost-effective public health interventions, we still lack evidence on the broader economic impact of vaccines, including the costs of illness of vaccine-preventable diseases like pneumonia, diarrhea and measles.

As part of the DOVE project’s fourth phase, researchers from the International Vaccine Access Center at Johns Hopkins University (IVAC), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), and Makerere University School of Public Health (MUSPH) have teamed up to empirically estimate the cost of pneumonia, diarrhea and measles in children under-five in Bangladesh and Uganda

Source: DOVE learning module #1 (January 2018).

The study collects utilization, cost, and expenditure data for the 2017-18 fiscal year, using a micro-costing approach. Six different surveys were developed to capture these data from the perspective of both the patients’ caretakers and the healthcare system. Facilities from the public and private (for-profit and not-) sectors, from rural and urban settings, and at every level of care were included. This research will help national and local stakeholders make more informed decisions about the true economic burden of childhood diseases—and provide evidence to support ongoing investment in the vaccines targeting these diseases.

For more information, please contact Gatien de Broucker